TRACK-HD is a multi-centre, multi-national prospective, observational biomarker study of premanifest and early stage HD with no experimental treatment.

Objectives

• determine what combination of measures is the most sensitive for detecting change over the natural course of premanifest and early HD
• to validate these as potential outcome measures for use in future therapeutic trials

• focused on intensive battery of novel assessments
• extensive annual assessments
• dynamic and fluid protocol
• robust evidence-based measures

Overview

• Recruitment began late 2007
• Study visits began January 2008
• Baseline visits (n=363) finished July 2008
• Database lock August 2008
• Analysis of baseline data underway
• Preliminary results expected soon
• Follow-up assessments start January 2009

Download a short summary:

trackhd